Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=61

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT05212948-fd393d94",
        "title": "S-268019-b vs Placebo: Number of Participants With First Occurrence of SARS-CoV-2 RT-PCR-Positive Severe COVID-19 in the Initial Vaccination Period With Onset at Least 14 Days Following Second Vaccination",
        "summary": "0 of 5181 against 1 of 2617; risk difference -0.0 points, 95% interval -0.2 to 0.0; NCT05212948, A Study of S-268019 for the Prevention of COVID-19",
        "record": "/library/comparisons/NCT05212948-fd393d94",
        "nct_id": "NCT05212948",
        "kind": "outcome",
        "participants": 7798,
        "risk_difference": {
          "value": -0.00038211692777990065,
          "lower": -0.0021613923961737846,
          "upper": 0.00042283460885081636
        },
        "group_1": "0 of 5,181",
        "group_2": "1 of 2,617",
        "difference": "-0.0 points",
        "interval": "-0.2 to 0.0",
        "trial_title": "A Study of S-268019 for the Prevention of COVID-19"
      },
      {
        "id": "NCT01488578-069e2f39",
        "title": "Male vs Female: Risk Factors for the Proportion of Responders of Tolterodine-Gender",
        "summary": "2745 of 3394 against 3791 of 4386; risk difference -5.6 points, 95% interval -7.2 to -3.9; NCT01488578, Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)",
        "record": "/library/comparisons/NCT01488578-069e2f39",
        "nct_id": "NCT01488578",
        "kind": "outcome",
        "participants": 7780,
        "risk_difference": {
          "value": -0.055560884917752684,
          "lower": -0.07231421914573122,
          "upper": -0.03897389369838444
        },
        "group_1": "2,745 of 3,394",
        "group_2": "3,791 of 4,386",
        "difference": "-5.6 points",
        "interval": "-7.2 to -3.9",
        "trial_title": "Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=62",
  "request_id": "8w8-xlWovtnfgZKr"
}